CareDx sharpens precision medicine focus with $260m Naveris acquisition
CareDx has agreed to acquire Naveris in a deal worth up to $260m, priming the company to inherit a blood‑based …
Post
-
-
Medtronic receives CE mark for Stealth surgical platform
Medtronic has received the CE mark for the Stealth AXiS surgical platform that combines planning, navigation, and robotics into a …
-
FDA approves Avatar Medical’s 3D image processing software
Avatar Medical’s software platform for processing CT and MR images into three-dimensional (3D) anatomical models has obtained US Food and …
-
Abbott secures FDA approval for Ultreon 3.0 imaging platform
Abbott has received the US Food and Drug Administration (FDA) approval and CE Mark for its Ultreon 3.0 AI-powered coronary …
-
High-quality steel: A prerequisite for safer surgical procedures
The margin for error in surgical procedures is extremely narrow, especially as clinical techniques become more advanced and minimally invasive. …
-
Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal
Thermo Fisher has agreed to sell its microbiology business in a deal above $1bn to private equity firm Astorg, reflecting …
-
Merck KGaA and Remepy join forces to develop combo drug-digital therapies
Merck KGaA has inked a collaboration deal with Israeli-US startup, Remepy, to explore the therapeutic potential of combination drug and …
-
iRhythm demonstrates value in 14-day monitoring for arrhythmia recurrence
New data from iRhythm Technologies has demonstrated that extending the cardiac monitoring duration for arrhythmia recurrence to 14 days resulted …
-
Tandem secures FDA approval for Control-IQ+ use in pregnancy
Tandem Diabetes Care has received approval from the US Food and Drug Administration (FDA) for its Control-IQ+ automated insulin delivery …
-
Nervonik closes $52.5m Series B funding to advance PNS system
US-based medical device company Nervonik has secured $52.5m in Series B financing aimed at advancing its peripheral nerve stimulation (PNS) …
-
HRS 2026: Medtronic, Boston Scientific and Abbott debut key PFA data
Boston Scientific, Abbott and Medtronic all presented successful readouts of their cardiac devices during the Heart Rhythm Society’s (HRS) 2026 …
-
Motif Neurotech secures FDA IDE to initiate depression implant study
The US Food and Drug Administration (FDA) has granted Motif Neurotech an investigational device exemption (IDE) to initiate a study …
-
J&J agrees to acquire Atraverse Medical to advance cardiac ablation portfolio
Johnson & Johnson (J&J) has agreed to acquire Atraverse Medical in a development that will give the medtech giant a …
-
Adagio Medical reports positive six-month results in FULCRUM-VT trial
Adagio Medical has reported positive six-month data from its pivotal FULCRUM-VT trial, supporting its plans to seek premarket approval from …
-
BrioHealth secures FDA approval to launch BrioVAD system trial
BrioHealth Solutions has secured conditional approval from the US Food and Drug Administration (FDA) to initiate a clinical trial of …
